Phase I/II trial investigating gedatolisib plus talazoparib in advanced triple negative or BRCA1/2 positive, HER2 negative breast cancers.
Saved in:
| Title: | Phase I/II trial investigating gedatolisib plus talazoparib in advanced triple negative or BRCA1/2 positive, HER2 negative breast cancers. |
|---|---|
| Authors: | Phadke S; Carver College of Medicine Department of Internal Medicine, University of Iowa, 200 Hawkins Drive, C21GH, Iowa City, IA, 52242, USA. Sneha-Phadke@uiowa.edu., Miller KD; Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Indianapolis, IN, USA., Shah A; Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., Danciu OC; University of Illinois Cancer Center, Chicago, IL, USA., Chen Y; Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI, USA., Yu M; Department of Biostatistics, University of Michigan - Ann Arbor, Ann Arbor, MI, USA., Burkard ME; Carver College of Medicine Department of Internal Medicine, University of Iowa, 200 Hawkins Drive, C21GH, Iowa City, IA, 52242, USA., Wisinski KB; Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.; Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Aug; Vol. 212 (3), pp. 521-530. Date of Electronic Publication: 2025 Jun 05. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40471518 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase I/II trial investigating gedatolisib plus talazoparib in advanced triple negative or BRCA1/2 positive, HER2 negative breast cancers. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Phadke+S%22">Phadke S</searchLink>; Carver College of Medicine Department of Internal Medicine, University of Iowa, 200 Hawkins Drive, C21GH, Iowa City, IA, 52242, USA. Sneha-Phadke@uiowa.edu.<br /><searchLink fieldCode="AU" term="%22Miller+KD%22">Miller KD</searchLink>; Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Shah+A%22">Shah A</searchLink>; Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Danciu+OC%22">Danciu OC</searchLink>; University of Illinois Cancer Center, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Yu+M%22">Yu M</searchLink>; Department of Biostatistics, University of Michigan - Ann Arbor, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Burkard+ME%22">Burkard ME</searchLink>; Carver College of Medicine Department of Internal Medicine, University of Iowa, 200 Hawkins Drive, C21GH, Iowa City, IA, 52242, USA.<br /><searchLink fieldCode="AU" term="%22Wisinski+KB%22">Wisinski KB</searchLink>; Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.; Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228111104%22">Breast cancer research and treatment</searchLink> [Breast Cancer Res Treat] 2025 Aug; Vol. 212 (3), pp. 521-530. <i>Date of Electronic Publication: </i>2025 Jun 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic%22">Kluwer Academic </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8111104 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7217 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676806%22">01676806 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res Treat <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40471518 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10549-025-07747-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 521 Titles: – TitleFull: Phase I/II trial investigating gedatolisib plus talazoparib in advanced triple negative or BRCA1/2 positive, HER2 negative breast cancers. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Phadke S – PersonEntity: Name: NameFull: Miller KD – PersonEntity: Name: NameFull: Shah A – PersonEntity: Name: NameFull: Danciu OC – PersonEntity: Name: NameFull: Chen Y – PersonEntity: Name: NameFull: Yu M – PersonEntity: Name: NameFull: Burkard ME – PersonEntity: Name: NameFull: Wisinski KB IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2025 Aug Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1573-7217 Numbering: – Type: volume Value: 212 – Type: issue Value: 3 Titles: – TitleFull: Breast cancer research and treatment Type: main |
| ResultId | 1 |
